Immunizations

Resource Center

FDA Alerts

Immunizations

FDA Approves First Dengue Vaccine in the US

05/03/2019

The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...

05/03/2019

Research Summaries

Research Summary

ACIP Releases 2024 Adult Immunization Schedule

03/26/2024

Jessica Ganga

The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...

03/26/2024

conference coverage

How Does Prior Influenza Vaccination Predict the Likelihood of Later Vaccinations for Influenza, COVID-19?

03/19/2024

Leigh Precopio

Researchers examined patterns among individuals who previously used preventative services and vaccinations and later vaccinations for both influenza and COVID-19 among US adults.

03/19/2024

Research Summary

CDC, AAP Release 2022-2023 Immunization Schedules for Children, Adolescents

04/04/2023

Jessica Ganga

The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.

04/04/2023

Vaccine Recommendations

ACIP Releases 2023 Adult Immunization Schedule

02/13/2023

The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.

02/13/2023

respiratory syncytial virus

RSV Long-Acting Antibody Effective in Protecting Infants, Reducing Hospitalization in Infants

01/24/2023

Researchers examined the effectiveness of the monoclonal antibody, nirsevimab, in protecting infants from the respiratory syncytial virus (RSV) and RSV lower respiratory tract infection.

01/24/2023

October 2024

Current Issue

October 2024

Volume 64

Issue 9